Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. méd. Chile ; 146(12): 1481-1485, dic. 2018. graf
Artigo em Espanhol | LILACS | ID: biblio-991360

RESUMO

We report a 45-year-old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycholate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma levels of voriconazole were insufficient with a standard dose (0.7 μg/mL), therefore, the dose was increased thereafter to reach appropriate levels (4.5 μg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Anfotericina B/efeitos adversos , Meningite Criptocócica/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Ácido Desoxicólico/efeitos adversos , Síndrome Inflamatória da Reconstituição Imune/induzido quimicamente , Voriconazol/administração & dosagem , Antifúngicos/efeitos adversos , Anfotericina B/administração & dosagem , Meningite Criptocócica/diagnóstico por imagem , Infecções Oportunistas Relacionadas com a AIDS/diagnóstico por imagem , Ácido Desoxicólico/administração & dosagem , Combinação de Medicamentos , Antifúngicos/administração & dosagem
2.
Rev Med Chil ; 146(12): 1481-1485, 2018 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-30848753

RESUMO

We report a 45-year-old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycholate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma levels of voriconazole were insufficient with a standard dose (0.7 µg/mL), therefore, the dose was increased thereafter to reach appropriate levels (4.5 µg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Anfotericina B/efeitos adversos , Antifúngicos/efeitos adversos , Ácido Desoxicólico/efeitos adversos , Síndrome Inflamatória da Reconstituição Imune/induzido quimicamente , Meningite Criptocócica/tratamento farmacológico , Voriconazol/administração & dosagem , Infecções Oportunistas Relacionadas com a AIDS/diagnóstico por imagem , Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Ácido Desoxicólico/administração & dosagem , Combinação de Medicamentos , Humanos , Masculino , Meningite Criptocócica/diagnóstico por imagem , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...